import type { MedicalCategory } from '../types';

// ğŸš¨ REVOLUTIONARY CLINICAL CASES - DEEP IMPLEMENTATION
// Based on actual Turkish medical education content provided by DrOzlemYildirim

// Enhanced interfaces for complete clinical case implementation
export interface MEPModule {
  id: string;
  title: string;
  description: string;
  category: MedicalCategory;
  language: 'turkish' | 'english' | 'bilingual';
  resources: string[];
  assessments: string[];
  estimatedTime: number;
  completed: boolean;
  difficulty: 'foundation' | 'intermediate' | 'advanced' | 'specialist';
  aiPrompts: string[];
  clinicalCases: ClinicalCase[];
  requiredSkills: string[];
  turkishMedicalTerms: { [key: string]: string };
  internationalGuidelines: string[];
  progress?: {
    completionPercentage: number;
    timeSpent: number;
    lastAccessed?: Date;
  };
  // NEW: Complete decision tree system
  decisionPoints?: DecisionPoint[];
  scoringSystem?: ScoringSystem;
  timeConstraints?: TimeConstraint[];
}

export interface ClinicalCase {
  id: string;
  title: string;
  patient: PatientInfo;
  presentation: string;
  diagnosticApproach: string[];
  treatment: string[];
  learningObjectives: string[];
  difficulty: 'easy' | 'medium' | 'hard';
  // NEW: Advanced clinical case features
  decisionTree: DecisionPoint[];
  vitalSigns: VitalSigns;
  labResults: LabResult[];
  imagingFindings?: string[];
  timeLimit?: number; // minutes
  scoringCriteria: ScoringCriteria[];
}

export interface PatientInfo {
  age: number;
  gender: 'male' | 'female';
  chiefComplaint: string;
  history: string;
  examination: string;
  investigations: string[];
  // NEW: Enhanced patient data
  comorbidities?: string[];
  medications?: string[];
  allergies?: string[];
  socialHistory?: string;
}

// NEW: Decision tree system for interactive cases
export interface DecisionPoint {
  id: string;
  timePoint: string; // e.g., "Ä°lk 2 dakika", "30. dakika"
  scenario: string;
  question: string;
  options: DecisionOption[];
  correctAnswer: string;
  explanation: string;
  consequences: { [key: string]: string };
  timeLimit?: number; // seconds
  hints?: string[];
}

export interface DecisionOption {
  id: string;
  text: string;
  isCorrect: boolean;
  points: number;
  riskImpact: number; // -3 to +3
  explanation: string;
  references?: string[];
}

export interface VitalSigns {
  heartRate: number;
  bloodPressure: string;
  temperature: number;
  oxygenSaturation: number;
  respiratoryRate: number;
  glasgow?: number;
}

export interface LabResult {
  test: string;
  value: string;
  normalRange: string;
  significance: string;
}

export interface ScoringCriteria {
  category: string;
  maxPoints: number;
  description: string;
}

export interface ScoringSystem {
  totalPoints: number;
  categories: {
    name: string;
    points: number;
    weight: number;
  }[];
  performanceLevels: {
    score: number;
    label: string;
    description: string;
  }[];
}

export interface TimeConstraint {
  phase: string;
  duration: number; // minutes
  criticalActions: string[];
}

/**
 * ğŸš¨ ACTUAL CLINICAL CASES FROM USER CONTENT
 * Revolutionary medical education with complete decision trees
 */

// ğŸš¨ VAKA 1: ACÄ°L SERVÄ°STTE SEPTÄ°K ÅOK - COMPLETE IMPLEMENTATION
export const septicShockCase: MEPModule = {
  id: 'case-septic-shock-complete',
  title: 'ğŸš¨ VAKA 1: ACÄ°L SERVÄ°STTE SEPTÄ°K ÅOK',
  description: 'Sepsis-3 kriterleri ve 1-saat bundle yÃ¶netimi - Tam karar aÄŸacÄ± ile interaktif Ã¶ÄŸrenme',
  category: 'emergency-medicine',
  language: 'bilingual',
  resources: [
    'Surviving Sepsis Campaign 2021 Guidelines',
    'IDSA Sepsis Management 2023 Update',
    'Turkish Society of Intensive Care Medicine Consensus',
    'qSOFA ve SOFA Skorlama Sistemleri'
  ],
  assessments: [
    'Interactive Decision Tree Assessment',
    '5-Point Clinical Decision Challenge',
    'Time-Constrained Management Simulation',
    'Turkish Emergency Medicine Protocol Test'
  ],
  estimatedTime: 45, // minutes
  completed: false,
  difficulty: 'advanced',
  aiPrompts: [
    'Sepsis-3 kriterlerine gÃ¶re bu hasta nasÄ±l deÄŸerlendirilir?',
    '1-saat bundle\'Ä±n doÄŸru sÄ±ralamasÄ± nedir?',
    'qSOFA vs SOFA skorlarÄ± arasÄ±ndaki fark nedir?',
    'VazopresÃ¶r baÅŸlama kriterleri nelerdir?',
    'TÃ¼rk yoÄŸun bakÄ±m kÄ±lavuzlarÄ±na gÃ¶re optimal yaklaÅŸÄ±m nedir?'
  ],
  clinicalCases: [{
    id: 'septic-shock-main-case',
    title: 'Septic Shock Decision Tree Challenge',
    patient: {
      age: 65,
      gender: 'female',
      chiefComplaint: 'AteÅŸ, titreme ve bilinÃ§ bulanÄ±klÄ±ÄŸÄ±',
      history: 'Son 2 gÃ¼ndÃ¼r artan ateÅŸ (39.2Â°C), idrar yaparken yanma, bugÃ¼n sabahtan beri konuÅŸmada yavaÅŸlama',
      examination: 'Glasgow 13 (konfÃ¼ze), cilt sÄ±cak ve nemli, kapiller geri dolum 4 saniye',
      investigations: ['Kan kÃ¼ltÃ¼rÃ¼', 'Ä°drar kÃ¼ltÃ¼rÃ¼', 'Laktat', 'ABG', 'Tam kan sayÄ±mÄ±', 'Biyokimya'],
      comorbidities: ['DM tip 2', 'Hipertansiyon'],
      medications: ['Metformin', 'ACE inhibitÃ¶rÃ¼'],
      allergies: ['Penisilin alerjisi'],
      socialHistory: 'Non-smoker, sosyal iÃ§ici deÄŸil'
    },
    presentation: '65 yaÅŸ kadÄ±n hasta, acil servise ateÅŸ, titreme ve bilinÃ§ bulanÄ±klÄ±ÄŸÄ± ÅŸikayetleri ile getirildi.',
    vitalSigns: {
      heartRate: 118,
      bloodPressure: '82/48 mmHg',
      temperature: 38.9,
      oxygenSaturation: 92,
      respiratoryRate: 26,
      glasgow: 13
    },
    labResults: [
      { test: 'Laktat', value: '4.2 mmol/L', normalRange: '<2 mmol/L', significance: 'YÃ¼ksek - doku perfÃ¼zyon bozukluÄŸu' },
      { test: 'WBC', value: '18,500/Î¼L', normalRange: '4,000-11,000/Î¼L', significance: 'YÃ¼ksek - enfeksiyon bulgusu' },
      { test: 'CRP', value: '285 mg/L', normalRange: '<10 mg/L', significance: 'Ã‡ok yÃ¼ksek - akut faz yanÄ±tÄ±' },
      { test: 'Kreatinin', value: '1.8 mg/dL', normalRange: '0.6-1.2 mg/dL', significance: 'YÃ¼ksek - bÃ¶brek yetmezliÄŸi' },
      { test: 'Prokalsitonin', value: '5.2 ng/mL', normalRange: '<0.25 ng/mL', significance: 'Ã‡ok yÃ¼ksek - bakteriyel sepsis' }
    ],
    decisionTree: [
      {
        id: 'decision-1',
        timePoint: 'Ä°lk 2 dakika',
        scenario: 'Hasta acil servise getirildi. Vital bulgularÄ±na gÃ¶re ilk mÃ¼dahale Ã¶nceliÄŸiniz nedir?',
        question: 'â“ KARAR NOKTASI 1: Ä°LK YAKLAÅIM\nZaman limiti: 2 dakika\n\nHastanÄ±n vital bulgularÄ±na gÃ¶re ilk mÃ¼dahale Ã¶nceliÄŸiniz nedir?',
        options: [
          {
            id: 'A',
            text: 'Ä°mmediately start norepinephrine infusion',
            isCorrect: false,
            points: 0,
            riskImpact: 1,
            explanation: 'VazopresÃ¶r sÄ±vÄ± resÃ¼sitasyonundan sonra baÅŸlanmalÄ±',
            references: ['Surviving Sepsis Campaign 2021']
          },
          {
            id: 'B',
            text: '30 mL/kg kristalloid sÄ±vÄ± resÃ¼sitasyonu',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! Septik ÅŸok\'ta ilk saat bundle\'Ä±nÄ±n en kritik komponenti sÄ±vÄ± resÃ¼sitasyonudur.',
            references: ['SSC 2021', 'SCCM Guidelines']
          },
          {
            id: 'C',
            text: 'GeniÅŸ spektrum antibiyotik baÅŸla',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'Antibiyotik Ã¶nemli ama Ã¶nce sÄ±vÄ± resÃ¼sitasyonu yapÄ±lmalÄ±',
            references: ['IDSA Guidelines']
          },
          {
            id: 'D',
            text: 'EntÃ¼basyon hazÄ±rlÄ±ÄŸÄ± yap',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'HenÃ¼z entÃ¼basyon endikasyonu yok, Ã¶nce sÄ±vÄ± ve destek tedavi'
          }
        ],
        correctAnswer: 'B',
        explanation: 'ğŸ’¡ Ä°pucu: Surviving Sepsis Campaign guidelines\'Ä± hatÄ±rlayÄ±n...\n\nâœ… DOÄRU CEVAP: B) 30 mL/kg kristalloid sÄ±vÄ± resÃ¼sitasyonu\n\nğŸ“ AÃ§Ä±klama: Septik ÅŸok\'ta ilk saat bundle\'Ä±nÄ±n en kritik komponenti sÄ±vÄ± resÃ¼sitasyonudur. Hipotansiyonu olan hastada Ã¶nce 30 mL/kg kristalloid verilmelidir.',
        consequences: {
          'A': 'PrematÃ¼re vazopresÃ¶r â†’ sÄ±vÄ± resÃ¼sitasyonu gecikir',
          'B': 'Optimal baÅŸlangÄ±Ã§ â†’ MAP yÃ¼kselme beklenir',
          'C': 'SÄ±vÄ± gecikimi â†’ hipotansiyon devam eder',
          'D': 'Gereksiz invaziv mÃ¼dahale riski'
        },
        timeLimit: 120,
        hints: [
          'Sepsis bundle sÄ±ralamasÄ± kritik',
          'Ä°lk Ã¶nce perfÃ¼zyonu dÃ¼zelt',
          'VazopresÃ¶r sÄ±vÄ±dan sonra gelir'
        ]
      },
      {
        id: 'decision-2',
        timePoint: '15. dakika - Lab Takibi',
        scenario: 'BaÅŸlangÄ±Ã§ lab sonuÃ§larÄ± geldi. SÄ±vÄ± resÃ¼sitasyonu sonrasÄ± deÄŸerlendirme.',
        question: 'â“ KARAR NOKTASI 2: LAB TAKÄ°BÄ°\n\nBaÅŸlangÄ±Ã§ lab sonuÃ§larÄ± geldi:\nâ€¢ Laktat: 4.2 mmol/L (N: <2)\nâ€¢ WBC: 18,500/Î¼L (bands %15)\nâ€¢ Kreatinin: 1.8 mg/dL (bazal 1.0)\nâ€¢ Prokalsitonin: 5.2 ng/mL (N: <0.25)\nâ€¢ SÄ±vÄ± resÃ¼sitasyonu sonrasÄ± TA: 85/52 mmHg\n\nBir sonraki adÄ±mÄ±nÄ±z?',
        options: [
          {
            id: 'A',
            text: 'Kan kÃ¼ltÃ¼rÃ¼ + antibiyotik baÅŸla',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! MAP >65 mmHg saÄŸlandÄ±ÄŸÄ±ndan vazopresÃ¶re henÃ¼z ihtiyaÃ§ yok. Åimdi odak araÅŸtÄ±rmasÄ± (kÃ¼ltÃ¼rler) ve 1 saat iÃ§inde antibiyotik ÅŸart.',
            references: ['Surviving Sepsis Campaign', 'IDSA 2023']
          },
          {
            id: 'B',
            text: 'VazopresÃ¶r (norepinephrine) baÅŸla',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'MAP 58 mmHg, henÃ¼z vazopresÃ¶r eÅŸiÄŸi deÄŸil (MAP <65)',
            references: ['SSC Guidelines']
          },
          {
            id: 'C',
            text: 'CVVH hazÄ±rlÄ±ÄŸÄ± yap',
            isCorrect: false,
            points: 0,
            riskImpact: 1,
            explanation: 'HenÃ¼z renal replasman tedavi endikasyonu yok'
          },
          {
            id: 'D',
            text: 'Steroid baÅŸla',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'Steroid vazopresÃ¶r ihtiyacÄ± olan hastalarda dÃ¼ÅŸÃ¼nÃ¼lÃ¼r'
          }
        ],
        correctAnswer: 'A',
        explanation: 'âœ… DOÄRU CEVAP: A) Kan kÃ¼ltÃ¼rÃ¼ + antibiyotik baÅŸla\n\nğŸ“ AÃ§Ä±klama: MAP >65 mmHg saÄŸlandÄ±ÄŸÄ±ndan vazopresÃ¶re henÃ¼z ihtiyaÃ§ yok. Åimdi odak araÅŸtÄ±rmasÄ± (kÃ¼ltÃ¼rler) ve 1 saat iÃ§inde antibiyotik ÅŸart.',
        consequences: {
          'A': 'Optimal sepsis bundle devam â†’ kaynak kontrol',
          'B': 'Erken vazopresÃ¶r â†’ gereksiz risk',
          'C': 'Premature CVVH â†’ komplikasyon riski',
          'D': 'Erken steroid â†’ enfeksiyon kontrolÃ¼ gecikir'
        },
        timeLimit: 90
      },
      {
        id: 'decision-3',
        timePoint: '45. dakika - Antibiyotik SeÃ§imi',
        scenario: 'Ä°drar kÃ¼ltÃ¼rÃ¼nde gram-pozitif kokklar gÃ¶rÃ¼ldÃ¼.',
        question: 'â“ KARAR NOKTASI 3: ANTÄ°BÄ°YOTÄ°K SEÃ‡Ä°MÄ°\n\nÄ°drar kÃ¼ltÃ¼rÃ¼nde gram-pozitif kokklar gÃ¶rÃ¼ldÃ¼.\n\nEn uygun empirik antibiyotik tedavi?',
        options: [
          {
            id: 'A',
            text: 'Piperacillin-tazobactam + Vancomycin',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! Kompllike Ã¼riner enfeksiyon + septik ÅŸok\'ta ESBL ve MRSA coverage gereklidir.',
            references: ['IDSA UTI Guidelines', 'Sepsis Guidelines']
          },
          {
            id: 'B',
            text: 'Ceftriaxone monoterapi',
            isCorrect: false,
            points: 5,
            riskImpact: 2,
            explanation: 'Yetersiz spektrum, septik ÅŸokta geniÅŸ spektrum gerekli',
            references: ['IDSA Guidelines']
          },
          {
            id: 'C',
            text: 'Meropenem monoterapi',
            isCorrect: false,
            points: 15,
            riskImpact: 0,
            explanation: 'Gram negatif coverage iyi ama MRSA coverage eksik',
            references: ['Antimicrobial Guidelines']
          },
          {
            id: 'D',
            text: 'Ampicillin-sulbactam',
            isCorrect: false,
            points: 0,
            riskImpact: 3,
            explanation: 'Yetersiz spektrum, septik ÅŸokta uygun deÄŸil'
          }
        ],
        correctAnswer: 'A',
        explanation: 'âœ… DOÄRU CEVAP: A) Piperacillin-tazobactam + Vancomycin\n\nğŸ“ AÃ§Ä±klama: Kompllike Ã¼riner enfeksiyon + septik ÅŸok\'ta ESBL ve MRSA coverage gereklidir.',
        consequences: {
          'A': 'Optimal antimikrobiyal spektrum â†’ enfeksiyon kontrolÃ¼',
          'B': 'Yetersiz tedavi â†’ klinik kÃ¶tÃ¼leÅŸme riski',
          'C': 'MRSA coverage eksik â†’ direnÃ§li enfeksiyon riski',
          'D': 'Ciddi yetersiz tedavi â†’ mortalite riski'
        },
        timeLimit: 60
      },
      {
        id: 'decision-4',
        timePoint: '3. saat - Takip DeÄŸerlendirmesi',
        scenario: '3. saatte: TA: 78/45 mmHg (MAP: 56 mmHg), Laktat: 3.8 mmol/L, Ä°drar Ã§Ä±kÄ±ÅŸÄ±: 15 mL/saat',
        question: 'â“ KARAR NOKTASI 4: TAKÄ°P\n\n3. saatte:\nâ€¢ TA: 78/45 mmHg (MAP: 56 mmHg)\nâ€¢ Laktat: 3.8 mmol/L\nâ€¢ Ä°drar Ã§Ä±kÄ±ÅŸÄ±: 15 mL/saat\n\nGerekli mÃ¼dahale?',
        options: [
          {
            id: 'A',
            text: 'Daha fazla sÄ±vÄ± ver (ek 1000 mL)',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'Zaten 30 mL/kg verildi, ÅŸimdi vazopresÃ¶r zamanÄ±',
            references: ['Fluid Responsiveness Studies']
          },
          {
            id: 'B',
            text: 'Norepinephrine infÃ¼zyon baÅŸla',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! 30 mL/kg sÄ±vÄ± sonrasÄ± MAP <65 mmHg ise vazopresÃ¶r endikasyonu vardÄ±r. Norepinephrine birinci seÃ§enektir.',
            references: ['Surviving Sepsis Campaign', 'Vasopressor Guidelines']
          },
          {
            id: 'C',
            text: 'Dobutamine ekle',
            isCorrect: false,
            points: 10,
            riskImpact: 1,
            explanation: 'Ä°notropik ajan, Ã¶nce vazokonstriksiyon gerekli',
            references: ['Hemodynamic Guidelines']
          },
          {
            id: 'D',
            text: 'Hemodiyaliz baÅŸla',
            isCorrect: false,
            points: 0,
            riskImpact: 2,
            explanation: 'HenÃ¼z RRT endikasyonu yok, Ã¶nce hemodinami dÃ¼zelmeli'
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) Norepinephrine infÃ¼zyon baÅŸla\n\nğŸ“ AÃ§Ä±klama: 30 mL/kg sÄ±vÄ± sonrasÄ± MAP <65 mmHg ise vazopresÃ¶r endikasyonu vardÄ±r. Norepinephrine birinci seÃ§enektir.',
        consequences: {
          'A': 'SÄ±vÄ± yÃ¼klenmesi â†’ pulmoner Ã¶dem riski',
          'B': 'Optimal vazopresÃ¶r â†’ MAP dÃ¼zelme beklenir',
          'C': 'Ä°notropik etki ama vazodilatÃ¶r â†’ MAP dÃ¼ÅŸer',
          'D': 'Premature RRT â†’ komplikasyon riski'
        },
        timeLimit: 90
      },
      {
        id: 'decision-5',
        timePoint: '12. saat - Prognoz DeÄŸerlendirmesi',
        scenario: '12. saatte: MAP: 68 mmHg, Laktat: 2.1 mmol/L, Ä°drar Ã§Ä±kÄ±ÅŸÄ±: 45 mL/saat, Bilinci aÃ§Ä±k',
        question: 'â“ KARAR NOKTASI 5: PROGNOZ DEÄERLENDÄ°RME\n\n12. saatte:\nâ€¢ MAP: 68 mmHg (norepinephrine 0.1 Î¼g/kg/dk)\nâ€¢ Laktat: 2.1 mmol/L\nâ€¢ Ä°drar Ã§Ä±kÄ±ÅŸÄ±: 45 mL/saat\nâ€¢ Bilinci aÃ§Ä±k, koopere\n\nBu hastanÄ±n kÄ±sa dÃ¶nem prognozunu nasÄ±l deÄŸerlendirirsiniz?',
        options: [
          {
            id: 'A',
            text: 'Mortalite riski %60-80 (Ã§ok yÃ¼ksek)',
            isCorrect: false,
            points: 5,
            riskImpact: 0,
            explanation: 'Ã‡ok kÃ¶tÃ¼mser, hastada iyileÅŸme bulgularÄ± var',
            references: ['SOFA Score Studies']
          },
          {
            id: 'B',
            text: 'Mortalite riski %30-40 (orta-yÃ¼ksek)',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'Hala kÃ¶tÃ¼mser, iyileÅŸme belirgin',
            references: ['Sepsis Outcome Studies']
          },
          {
            id: 'C',
            text: 'Mortalite riski %10-15 (dÃ¼ÅŸÃ¼k)',
            isCorrect: true,
            points: 20,
            riskImpact: -1,
            explanation: 'DoÄŸru! Erken tanÄ± + uygun tedavi ile laktat clearing + organ fonksiyon dÃ¼zelimi olmasÄ± prognozu iyileÅŸtirir.',
            references: ['Sepsis Outcome Predictors', 'SOFA Trend Analysis']
          },
          {
            id: 'D',
            text: 'Tam iyileÅŸme garantili',
            isCorrect: false,
            points: 0,
            riskImpact: -1,
            explanation: 'AÅŸÄ±rÄ± iyimser, sepsis her zaman risk taÅŸÄ±r'
          }
        ],
        correctAnswer: 'C',
        explanation: 'âœ… DOÄRU CEVAP: C) Mortalite riski %10-15 (dÃ¼ÅŸÃ¼k)\n\nğŸ“ AÃ§Ä±klama: Erken tanÄ± + uygun tedavi ile laktat clearing + organ fonksiyon dÃ¼zelimi olmasÄ± prognozu iyileÅŸtirir.',
        consequences: {
          'A': 'AÅŸÄ±rÄ± kÃ¶tÃ¼mser â†’ hasta ve aile kaygÄ±sÄ±',
          'B': 'KÃ¶tÃ¼mser â†’ gereksiz yoÄŸun mÃ¼dahale',
          'C': 'GerÃ§ekÃ§i prognoz â†’ uygun planlama',
          'D': 'AÅŸÄ±rÄ± iyimser â†’ dikkat azalmasÄ± riski'
        },
        timeLimit: 120
      }
    ],
    diagnosticApproach: [
      'qSOFA ve SOFA skorlamasÄ±',
      'Sepsis-3 kriterlerine gÃ¶re deÄŸerlendirme',
      'Kaynak enfeksiyon araÅŸtÄ±rmasÄ±',
      'Organ yetmezliÄŸi deÄŸerlendirmesi',
      'Hemodinamik monitÃ¶rizasyon'
    ],
    treatment: [
      '1-Saat Bundle uygulamasÄ±',
      '30 mL/kg kristalloid resÃ¼sitasyonu',
      'KÃ¼ltÃ¼r + geniÅŸ spektrum antibiyotik',
      'VazopresÃ¶r desteÄŸi (MAP >65 mmHg)',
      'Kaynak kontrolÃ¼'
    ],
    learningObjectives: [
      'Sepsis-3 kriterlerini uygulayabilmek',
      '1-saat bundle\'Ä± doÄŸru sÄ±rada yapabilmek',
      'VazopresÃ¶r baÅŸlama kriterlerini bilmek',
      'Antibiyotik seÃ§imini uygun yapabilmek',
      'Prognoz deÄŸerlendirmesi yapabilmek'
    ],
    difficulty: 'hard',
    timeLimit: 45, // minutes for complete case
    scoringCriteria: [
      { category: 'Kritik Kararlar', maxPoints: 60, description: 'DoÄŸru sÄ±ralama ve zamanÄ±nda mÃ¼dahale' },
      { category: 'Zaman PerformansÄ±', maxPoints: 25, description: 'HÄ±zlÄ± ve doÄŸru karar verme' },
      { category: 'Komplikasyon Riski', maxPoints: 15, description: 'Risk minimizasyonu' }
    ]
  }],
  requiredSkills: [
    'Sepsis tanÄ± kriterleri',
    'Emergency resuscitation',
    'Antibiotic stewardship',
    'Hemodynamic monitoring',
    'Critical care principles',
    'Turkish emergency protocols'
  ],
  turkishMedicalTerms: {
    'sepsis': 'sepsis',
    'septic shock': 'septik ÅŸok',
    'resuscitation': 'resÃ¼sitasyon',
    'vasopressor': 'vazopresÃ¶r',
    'norepinephrine': 'norepinefrin',
    'crystalloid': 'kristalloid',
    'antibiotic': 'antibiyotik',
    'source control': 'kaynak kontrolÃ¼',
    'lactate clearance': 'laktat klirensÄ±',
    'mean arterial pressure': 'ortalama arter basÄ±ncÄ±'
  },
  internationalGuidelines: [
    'Surviving Sepsis Campaign 2021 Guidelines',
    'IDSA Sepsis Management 2023 Update',
    'Turkish Society of Intensive Care Medicine Consensus',
    'SCCM/ESICM Sepsis Guidelines'
  ],
  scoringSystem: {
    totalPoints: 100,
    categories: [
      { name: 'Kritik Kararlar', points: 60, weight: 0.6 },
      { name: 'Zaman YÃ¶netimi', points: 25, weight: 0.25 },
      { name: 'Risk YÃ¶netimi', points: 15, weight: 0.15 }
    ],
    performanceLevels: [
      { score: 90, label: 'Uzman Seviyesi', description: 'Sepsis yÃ¶netiminde excellence' },
      { score: 75, label: 'Yetkin Seviyesi', description: 'Ä°yi klinik performans' },
      { score: 60, label: 'GeliÅŸtirilmeli', description: 'Temel bilgi var, pratik gerekli' },
      { score: 0, label: 'Ciddi EÄŸitim Ä°htiyacÄ±', description: 'KapsamlÄ± eÄŸitim gerekli' }
    ]
  },
  timeConstraints: [
    { phase: 'Ä°lk DeÄŸerlendirme', duration: 2, criticalActions: ['ABC', 'Vital signs', 'qSOFA'] },
    { phase: 'ResÃ¼sitasyon BaÅŸlangÄ±cÄ±', duration: 15, criticalActions: ['30 mL/kg sÄ±vÄ±', 'Kan kÃ¼ltÃ¼rÃ¼', 'IV access'] },
    { phase: '1-Saat Bundle', duration: 60, criticalActions: ['Antibiyotik', 'Kaynak araÅŸtÄ±rma', 'Laktat follow-up'] },
    { phase: 'VazopresÃ¶r DeÄŸerlendirmesi', duration: 180, criticalActions: ['MAP monitoring', 'Norepinephrine', 'Ä°drar takibi'] },
    { phase: 'Ä°yileÅŸme Ä°zlemi', duration: 720, criticalActions: ['Laktat clearing', 'Organ fonksiyon', 'Prognoz'] }
  ]
};

/**
 * ğŸ’” VAKA 2: STEMI AKUT YÃ–NETÄ°MÄ° - COMPLETE IMPLEMENTATION
 */
export const stemiCase: MEPModule = {
  id: 'case-stemi-complete',
  title: 'ğŸ’” VAKA 2: STEMI AKUT YÃ–NETÄ°MÄ°',
  description: 'Door-to-balloon optimization ve RV infarkt yÃ¶netimi - Tam protokol implementasyonu',
  category: 'cardiology',
  language: 'bilingual',
  resources: [
    '2023 ACC/AHA STEMI Guidelines',
    '2017 ESC STEMI Management',
    'TSC (TÃ¼rk Kardiyoloji DerneÄŸi) Konsensus 2022',
    'Door-to-Balloon Quality Measures'
  ],
  assessments: [
    'EKG Ä°nterpretasyon Challenge',
    'Reperfusion Strategy Selection',
    'Door-to-Balloon Time Optimization',
    'RV Infarct Management Protocol'
  ],
  estimatedTime: 40,
  completed: false,
  difficulty: 'advanced',
  aiPrompts: [
    'Bu EKG bulgularÄ±nÄ±n anatomik korelasyonu nedir?',
    'Door-to-balloon vs door-to-needle kararÄ± nasÄ±l verilir?',
    'RV infarkt bulgularÄ± nasÄ±l deÄŸerlendirilir?',
    'Reperfusion stratejisi seÃ§im kriterleri nelerdir?',
    'TÃ¼rk kardiyoloji kÄ±lavuzlarÄ±na gÃ¶re optimal yaklaÅŸÄ±m?'
  ],
  clinicalCases: [{
    id: 'stemi-main-case',
    title: 'STEMI Management Decision Challenge',
    patient: {
      age: 58,
      gender: 'male',
      chiefComplaint: 'GÃ¶ÄŸÃ¼s aÄŸrÄ±sÄ± ve terleme',
      history: '2 saat Ã¶nce baÅŸlayan, crushing tarzÄ± gÃ¶ÄŸÃ¼s aÄŸrÄ±sÄ±, sol kola yayÄ±lan aÄŸrÄ±, terleme',
      examination: 'S4 galop (+), mitral Ã¼fÃ¼rÃ¼m yok, akciÄŸer bazillerde minimal raller',
      investigations: ['12-derivasyon EKG', '18-lead EKG', 'Kardiyak enzimler', 'AkciÄŸer grafisi'],
      comorbidities: ['Sigara (20 paket/yÄ±l)', 'Hipertansiyon'],
      medications: ['ACE inhibitÃ¶rÃ¼'],
      allergies: ['Bilinen ilaÃ§ alerjisi yok'],
      socialHistory: 'Aile Ã¶ykÃ¼sÃ¼nde erken koroner hastalÄ±k (+)'
    },
    presentation: '58 yaÅŸ erkek hasta, gÃ¶ÄŸÃ¼s aÄŸrÄ±sÄ± ÅŸikayeti ile acil servise baÅŸvurdu.',
    vitalSigns: {
      heartRate: 68,
      bloodPressure: '140/85 mmHg',
      temperature: 36.5,
      oxygenSaturation: 96,
      respiratoryRate: 18
    },
    labResults: [
      { test: 'Troponin I', value: '25.6 ng/mL', normalRange: '<0.04 ng/mL', significance: 'Ã‡ok yÃ¼ksek - akut MI' },
      { test: 'CK-MB', value: '45 ng/mL', normalRange: '<6.3 ng/mL', significance: 'YÃ¼ksek - miyokard hasarÄ±' },
      { test: 'D-dimer', value: '150 ng/mL', normalRange: '<500 ng/mL', significance: 'Normal' },
      { test: 'NT-proBNP', value: '450 pg/mL', normalRange: '<125 pg/mL', significance: 'YÃ¼ksek - kalp yetmezliÄŸi riski' }
    ],
    imagingFindings: [
      'EKG: ST elevasyonu D2, D3, aVF derivasyonlarÄ±nda (3mm)',
      '18-lead EKG: V3R, V4R derivasyonlarÄ±nda ST elevasyonu (+)',
      'AkciÄŸer grafisi: Kardiyomegali yok, pulmoner konjesyon yok'
    ],
    decisionTree: [
      {
        id: 'stemi-decision-1',
        timePoint: 'Ä°lk 10 dakika - TanÄ±sal YaklaÅŸÄ±m',
        scenario: 'EKG: ST elevasyonu D2, D3, aVF derivasyonlarÄ±nda. Bu EKG bulgularÄ± hangi koroner anatomiyi iÅŸaret eder?',
        question: 'â“ KARAR NOKTASI 1: TANSAL YAKLAÅÄ°M\nZaman limiti: 3 dakika\n\nBu EKG bulgularÄ± hangi koroner anatomiyi iÅŸaret eder?',
        options: [
          {
            id: 'A',
            text: 'LAD (Left Anterior Descending) proksimal oklÃ¼zyon',
            isCorrect: false,
            points: 0,
            riskImpact: 1,
            explanation: 'LAD oklÃ¼zyonu anterior derivasyonlarda (V1-V6) ST elevasyonu yapar',
            references: ['EKG Interpretation Guide']
          },
          {
            id: 'B',
            text: 'RCA (Right Coronary Artery) oklÃ¼zyon',
            isCorrect: true,
            points: 25,
            riskImpact: -1,
            explanation: 'DoÄŸru! D2, D3, aVF\'de ST elevasyonu inferior MI\'yi gÃ¶sterir ve tipik olarak RCA oklÃ¼zyonuna baÄŸlÄ±dÄ±r.',
            references: ['Coronary Anatomy', 'EKG Localization']
          },
          {
            id: 'C',
            text: 'LCX (Left Circumflex) oklÃ¼zyon',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'LCX genelde lateral derivasyonlarda (I, aVL, V5-V6) deÄŸiÅŸiklik yapar',
            references: ['Coronary Territory Guide']
          },
          {
            id: 'D',
            text: 'Left main coronary artery oklÃ¼zyon',
            isCorrect: false,
            points: 5,
            riskImpact: 2,
            explanation: 'Left main tÃ¼m anterior derivasyonlarda yaygÄ±n ST deÄŸiÅŸiklikleri yapar',
            references: ['High-risk ACS Guidelines']
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) RCA (Right Coronary Artery) oklÃ¼zyon\n\nğŸ“ AÃ§Ä±klama: D2, D3, aVF\'de ST elevasyonu inferior MI\'yi gÃ¶sterir ve tipik olarak RCA oklÃ¼zyonuna baÄŸlÄ±dÄ±r.',
        consequences: {
          'A': 'YanlÄ±ÅŸ lokalizasyon â†’ yanlÄ±ÅŸ risk deÄŸerlendirmesi',
          'B': 'DoÄŸru tanÄ± â†’ uygun reperfÃ¼zyon stratejisi',
          'C': 'Anatomik hata â†’ komplikasyon gÃ¶zden kaÃ§abilir',
          'D': 'AÅŸÄ±rÄ± alarm â†’ gereksiz yoÄŸun mÃ¼dahale'
        },
        timeLimit: 180
      },
      {
        id: 'stemi-decision-2',
        timePoint: '15. dakika - Komplikasyon AraÅŸtÄ±rmasÄ±',
        scenario: '18-lead EKG: V3R, V4R derivasyonlarÄ±nda ST elevasyonu (+). Bu bulgu ne anlama gelir?',
        question: 'â“ KARAR NOKTASI 2: KOMPLÄ°KASYON ARAÅTIRMASI\n\n18-lead EKG: V3R, V4R derivasyonlarÄ±nda ST elevasyonu (+)\n\nBu bulgu ne anlama gelir?',
        options: [
          {
            id: 'A',
            text: 'Posterior MI eklendi',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'Posterior MI iÃ§in V7-V9 derivasyonlarÄ± gerekli',
            references: ['Posterior MI Diagnosis']
          },
          {
            id: 'B',
            text: 'SaÄŸ ventrikÃ¼l infarktÄ± var',
            isCorrect: true,
            points: 25,
            riskImpact: -2,
            explanation: 'DoÄŸru! Inferior MI + saÄŸ prekordiyel derivasyonlarda ST elevasyonu RV infarktÄ±nÄ± gÃ¶sterir. Bu durum Ã¶zel yÃ¶netim gerektirir.',
            references: ['RV Infarct Guidelines', 'Right Heart Catheterization']
          },
          {
            id: 'C',
            text: 'Atriyal infarkt mevcut',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'Atriyal infarkt Ã§ok nadir ve farklÄ± EKG bulgularÄ± verir',
            references: ['Rare MI Patterns']
          },
          {
            id: 'D',
            text: 'Sadece artifakt',
            isCorrect: false,
            points: 0,
            riskImpact: 3,
            explanation: 'V4R\'de ST elevasyonu ciddi bulgu, gÃ¶z ardÄ± edilmemeli',
            references: ['EKG Artifact Recognition']
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) SaÄŸ ventrikÃ¼l infarktÄ± var\n\nğŸ“ AÃ§Ä±klama: Inferior MI + saÄŸ prekordiyel derivasyonlarda ST elevasyonu RV infarktÄ±nÄ± gÃ¶sterir. Bu durum Ã¶zel yÃ¶netim gerektirir.',
        consequences: {
          'A': 'YanlÄ±ÅŸ tanÄ± â†’ yanlÄ±ÅŸ tedavi yaklaÅŸÄ±mÄ±',
          'B': 'DoÄŸru tanÄ± â†’ RV infarkt protokolÃ¼ baÅŸlar',
          'C': 'NadÄ±r tanÄ± â†’ gereksiz araÅŸtÄ±rma',
          'D': 'Kritik bulgu gÃ¶zden kaÃ§ar â†’ RV yetmezliÄŸi riski'
        },
        timeLimit: 120
      },
      {
        id: 'stemi-decision-3',
        timePoint: '25. dakika - ReperfÃ¼zyon Stratejisi',
        scenario: 'Hastane durumu: Primer PCI imkanÄ± YOK, En yakÄ±n PCI merkezi 90 dakika uzaklÄ±kta, tPA stoku mevcut, Semptom baÅŸlangÄ±cÄ±: 2.5 saat Ã¶nce',
        question: 'â“ KARAR NOKTASI 3: REPERFÃœZÄ°ON STRATEJÄ°SÄ°\n\nHastane durumu:\nâ€¢ Primer PCI imkanÄ± YOK\nâ€¢ En yakÄ±n PCI merkezi 90 dakika uzaklÄ±kta\nâ€¢ tPA stoku mevcut\nâ€¢ Semptom baÅŸlangÄ±cÄ±: 2.5 saat Ã¶nce\n\nEn uygun reperfÃ¼zyon stratejisi?',
        options: [
          {
            id: 'A',
            text: 'Ä°mmediately tPA + transfer for rescue PCI if needed',
            isCorrect: true,
            points: 30,
            riskImpact: -2,
            explanation: 'DoÄŸru! Door-to-balloon time >120 dk ise fibrinolitik tedavi Ã¶nceliklidir (door-to-needle <30 dk hedefi).',
            references: ['Reperfusion Strategy Guidelines', 'STEMI Networks']
          },
          {
            id: 'B',
            text: 'Transfer for primary PCI (2 saatlik transport)',
            isCorrect: false,
            points: 15,
            riskImpact: 1,
            explanation: 'Transfer sÃ¼re >120dk, fibrinolitik daha avantajlÄ±',
            references: ['Door-to-Balloon Guidelines']
          },
          {
            id: 'C',
            text: 'Conservative management (no reperfusion)',
            isCorrect: false,
            points: 0,
            riskImpact: 3,
            explanation: 'STEMI\'de reperfÃ¼zyon mutlak endikasyon',
            references: ['STEMI Guidelines']
          },
          {
            id: 'D',
            text: 'Heparin + antiaggregant therapy only',
            isCorrect: false,
            points: 5,
            riskImpact: 3,
            explanation: 'Medical therapy tek baÅŸÄ±na yetersiz',
            references: ['Antiplatelet Guidelines']
          }
        ],
        correctAnswer: 'A',
        explanation: 'âœ… DOÄRU CEVAP: A) Ä°mmediately tPA + transfer for rescue PCI if needed\n\nğŸ“ AÃ§Ä±klama: Door-to-balloon time >120 dk ise fibrinolitik tedavi Ã¶nceliklidir (door-to-needle <30 dk hedefi).',
        consequences: {
          'A': 'Optimal reperfusion â†’ miyokard kurtarma maksimal',
          'B': 'Geciken reperfusion â†’ daha fazla miyokard kaybÄ±',
          'C': 'Reperfusion yok â†’ masif infarkt riski',
          'D': 'Yetersiz tedavi â†’ kÃ¶tÃ¼ prognoz'
        },
        timeLimit: 180
      }
    ],
    diagnosticApproach: [
      '12-derivasyon EKG analizi',
      '18-lead EKG (RV derivasyonlarÄ±)',
      'Kardiyak biomarker Ã¶lÃ§Ã¼mÃ¼',
      'Reperfusion stratejisi belirleme',
      'Door-to-needle/balloon zaman optimizasyonu'
    ],
    treatment: [
      'Dual antiplatelet therapy (ASA + P2Y12)',
      'Fibrinolitik tedavi (tPA)',
      'AntikoagÃ¼lan tedavi',
      'RV infarkt Ã¶zel yÃ¶netimi',
      'Rescue PCI hazÄ±rlÄ±ÄŸÄ±'
    ],
    learningObjectives: [
      'STEMI tanÄ± kriterlerini uygulamak',
      'RV infarkt bulgularÄ±nÄ± tanÄ±mak',
      'Reperfusion strategy seÃ§imi yapabilmek',
      'Door-to-needle time optimize etmek',
      'Post-MI komplikasyonlarÄ± Ã¶ngÃ¶rmek'
    ],
    difficulty: 'hard',
    timeLimit: 40,
    scoringCriteria: [
      { category: 'TanÄ±sal DoÄŸruluk', maxPoints: 30, description: 'EKG yorumu ve komplikasyon tanÄ±ma' },
      { category: 'Reperfusion ZamanlamasÄ±', maxPoints: 35, description: 'DoÄŸru strateji ve timing' },
      { category: 'Komplikasyon YÃ¶netimi', maxPoints: 25, description: 'RV infarkt ve hipotansiyon' },
      { category: 'Transfer KararÄ±', maxPoints: 10, description: 'Risk-benefit deÄŸerlendirme' }
    ]
  }],
  requiredSkills: [
    'EKG interpretation',
    'Coronary anatomy knowledge',
    'Reperfusion strategies',
    'RV infarct management',
    'Time-critical decision making',
    'Turkish cardiology protocols'
  ],
  turkishMedicalTerms: {
    'STEMI': 'ST elevasyonlu miyokard infarktÃ¼sÃ¼',
    'primary PCI': 'primer perkÃ¼tan koroner giriÅŸim',
    'door-to-balloon': 'kapÄ±-balon sÃ¼resi',
    'door-to-needle': 'kapÄ±-iÄŸne sÃ¼resi',
    'fibrinolytic': 'fibrinolitik',
    'reperfusion': 'reperfÃ¼zyon',
    'RV infarct': 'saÄŸ ventrikÃ¼l infarktÄ±',
    'rescue PCI': 'kurtarma PGÄ°',
    'dual antiplatelet': 'ikili antiplatelet',
    'biomarkers': 'biyobelirteÃ§ler'
  },
  internationalGuidelines: [
    '2023 ACC/AHA STEMI Guidelines',
    '2017 ESC STEMI Management',
    'Turkish Society of Cardiology Consensus 2022',
    'Door-to-Balloon Quality Measures'
  ]
};

// ğŸš¨ VAKA 3: STATUS EPÄ°LEPTÄ°KUS - NEUROLOGÄ° ACÄ°L DURUMU
export const statusEpilepticusCase: MEPModule = {
  id: 'case-status-epilepticus-complete',
  title: 'âš¡ VAKA 3: STATUS EPÄ°LEPTÄ°KUS - NEUROLOJÄ°K ACÄ°L DURUM',
  description: 'Status epilepticus - nÃ¶rolojik acil durum yÃ¶netimi ve stepwise approach. TÃ¼rk NÃ¶roloji DerneÄŸi kÄ±lavuzlarÄ± ile uyumlu tam protokol.',
  category: 'emergency-medicine',
  language: 'bilingual',
  resources: [
    'Status Epilepticus Management Protocol',
    'AES Guidelines 2023',
    'Turkish Neurology Society Guidelines',
    'EEG interpretation basics'
  ],
  assessments: ['Decision Tree Analysis', 'Time-Critical Management', 'Drug Selection Rationale'],
  estimatedTime: 2.5,
  completed: false,
  difficulty: 'advanced',
  aiPrompts: [
    'CRITICAL: Status epilepticus tanÄ± ve tedavi protokolÃ¼nÃ¼ TÃ¼rk kÄ±lavuzlarÄ± ile karÅŸÄ±laÅŸtÄ±r',
    'Anti-epileptik ilaÃ§ seÃ§iminde pediatrik vs adult farklÄ±lÄ±klarÄ±',
    'EEG monitorizasyon gerekliliÄŸi ve timing'
  ],
  requiredSkills: [
    'Status epilepticus immediate recognition',
    'Stepwise anti-epileptic drug protocol',
    'Airway management in seizures',
    'EEG interpretation basics',
    'Turkish neurology guidelines compliance'
  ],
  turkishMedicalTerms: {
    'status epilepticus': 'status epileptikus',
    'convulsive SE': 'konvÃ¼lsif SE',
    'non-convulsive SE': 'non-konvÃ¼lsif SE',
    'breakthrough seizures': 'breakthrough nÃ¶betler',
    'refractory SE': 'refrakter SE',
    'super-refractory SE': 'sÃ¼per-refrakter SE'
  },
  internationalGuidelines: [
    '2023 AES Status Epilepticus Guidelines',
    'Turkish Neurology Society Consensus 2022',
    '2019 ESICM/EAN Guidelines'
  ],
  clinicalCases: [{
    id: 'status-epilepticus-main',
    title: 'âš¡ 28Y Male - Status Epilepticus',
    patient: {
      age: 28,
      gender: 'male',
      chiefComplaint: 'SÃ¼rekli nÃ¶bet, 15 dakikadÄ±r durmayan',
      history: 'Epilepsi tanÄ±sÄ± yok, alkol kullanÄ±m Ã¶ykÃ¼sÃ¼ var, 15 dakikadÄ±r sÃ¼rekli tonik-klonik nÃ¶bet',
      examination: 'BilinÃ§siz, sÃ¼rekli nÃ¶bet aktivitesi, refleksler hiperrefletik',
      investigations: ['EEG', 'Kraniyal CT', 'Glukoz', 'Elektrolit paneli'],
      comorbidities: ['Alkol kullanÄ±m bozukluÄŸu']
    },
    presentation: '28 yaÅŸÄ±nda erkek hasta, 15 dakikadÄ±r sÃ¼rekli tonik-klonik nÃ¶bet geÃ§iriyor. Ailesi geÃ§ fark etmiÅŸ, ambulans Ã§aÄŸÄ±rÄ±lmÄ±ÅŸ.',
    vitalSigns: {
      heartRate: 135,
      bloodPressure: '165/95',
      temperature: 38.2,
      respiratoryRate: 28,
      oxygenSaturation: 89,
      glasgow: 6
    },
    labResults: [
      { test: 'Glukoz', value: '65 mg/dL (DÃ¼ÅŸÃ¼k)', normalRange: '70-110 mg/dL', significance: 'abnormal' },
      { test: 'Na', value: '128 mEq/L (DÃ¼ÅŸÃ¼k)', normalRange: '135-145 mEq/L', significance: 'abnormal' },
      { test: 'Laktat', value: '4.8 mmol/L (YÃ¼ksek)', normalRange: '<2.0 mmol/L', significance: 'critical' },
      { test: 'pH', value: '7.28 (Asidoz)', normalRange: '7.35-7.45', significance: 'critical' },
      { test: 'Alkol', value: '180 mg/dL (YÃ¼ksek)', normalRange: '0 mg/dL', significance: 'abnormal' }
    ],
    decisionTree: [
      {
        id: 'se-decision-1',
        timePoint: 'Ä°lk 5 dakika - Acil MÃ¼dahale',
        scenario: '15 dakikadÄ±r sÃ¼rekli nÃ¶bet geÃ§iren hasta acil servise getirildi. SaO2: %89, nabÄ±z: 135/dk',
        question: 'â“ KARAR NOKTASI 1: HAVAYOLU ve Ä°LK MÃœDAHALE\nZaman limiti: 2 dakika\n\nStatus epilepticus tanÄ±sÄ± konuldu. Ä°lk Ã¶nceliÄŸiniz nedir?',
        options: [
          {
            id: 'A',
            text: 'IV lorazepam 4mg yavaÅŸ push',
            isCorrect: false,
            points: 15,
            riskImpact: 0,
            explanation: 'IV benzodiazepine geÃ§meden Ã¶nce havayolu gÃ¼venliÄŸi saÄŸlanmalÄ±',
            references: ['AES Guidelines 2023']
          },
          {
            id: 'B',
            text: 'Havayolu gÃ¼venliÄŸi + O2 + IV access',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! Status epilepticus\'ta ilk Ã¶ncelik havayolu gÃ¼venliÄŸi, oksijenizasyon ve IV eriÅŸim',
            references: ['Turkish Emergency Medicine Guidelines']
          },
          {
            id: 'C',
            text: 'Derhal entÃ¼basyon hazÄ±rlÄ±ÄŸÄ±',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'Premature entÃ¼basyon. Ã–nce benzodiazepine denenebilir'
          },
          {
            id: 'D',
            text: 'EEG monitoring baÅŸlat',
            isCorrect: false,
            points: 0,
            riskImpact: 2,
            explanation: 'EEG sonraya bÄ±rakÄ±lÄ±r, acil mÃ¼dahale Ã¶ncelik'
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) Havayolu gÃ¼venliÄŸi + O2 + IV access\n\nğŸ“ AÃ§Ä±klama: Status epilepticus\'ta ABC yaklaÅŸÄ±mÄ± kritik. Havayolu, solunum, dolaÅŸÄ±m gÃ¼venliÄŸi Ã¶ncelik.',
        consequences: {
          'A': 'Havayolu gÃ¼venliÄŸi risk altÄ±nda',
          'B': 'Optimal baÅŸlangÄ±Ã§ â†’ gÃ¼venli ilaÃ§ uygulamasÄ±',
          'C': 'Gereksiz invaziv mÃ¼dahale riski',
          'D': 'Kritik zaman kaybÄ±'
        },
        timeLimit: 120,
        hints: ['ABC yaklaÅŸÄ±mÄ± unutma', 'Ä°V eriÅŸim ÅŸart', 'Oksijenizasyon kritik']
      },
      {
        id: 'se-decision-2',
        timePoint: '7. dakika - Benzodiazepin AÅŸamasÄ±',
        scenario: 'Havayolu gÃ¼venliÄŸi saÄŸlandÄ±, IV eriÅŸim var, O2 verildi. NÃ¶bet devam ediyor.',
        question: 'â“ KARAR NOKTASI 2: BENZODÄ°AZEPÄ°N SEÃ‡Ä°MÄ°\n\nHavayolu gÃ¼venliÄŸi saÄŸlandÄ±, IV eriÅŸim mevcut. NÃ¶bet 20 dakikadÄ±r devam ediyor.\n\nÄ°lk line benzodiazepin seÃ§iminiz?',
        options: [
          {
            id: 'A',
            text: 'Midazolam 10mg IM',
            isCorrect: false,
            points: 10,
            riskImpact: 0,
            explanation: 'IV eriÅŸim var ise IV tercih edilir',
            references: ['AES Guidelines']
          },
          {
            id: 'B',
            text: 'Lorazepam 0.1mg/kg IV (max 4mg)',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! IV lorazepam first-line, daha uzun etki sÃ¼resi',
            references: ['AES 2023', 'Turkish Neurology Guidelines']
          },
          {
            id: 'C',
            text: 'Diazepam 0.15mg/kg IV',
            isCorrect: false,
            points: 15,
            riskImpact: -1,
            explanation: 'Alternatif seÃ§enek ama lorazepam preferred',
            references: ['WHO Guidelines']
          },
          {
            id: 'D',
            text: 'Phenytoin 20mg/kg yÃ¼kleme',
            isCorrect: false,
            points: 5,
            riskImpact: 1,
            explanation: 'Phenytoin 2nd line, Ã¶nce benzodiazepin denenmelidir'
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) Lorazepam 0.1mg/kg IV (max 4mg)\n\nğŸ“ AÃ§Ä±klama: Lorazepam first-line IV benzodiazepin, uzun etki sÃ¼resi ve etkili penetrasyon.',
        consequences: {
          'A': 'IV route daha etkili olurdu',
          'B': 'Optimal benzodiazepin seÃ§imi',
          'C': 'Acceptable ama lorazepam daha iyi',
          'D': '2nd line\'a erken geÃ§iÅŸ'
        },
        timeLimit: 90
      }
    ],
    diagnosticApproach: ['Status epilepticus recognition', 'Airway assessment', 'EEG if available', 'Metabolic workup'],
    treatment: ['ABC approach', 'IV benzodiazepines', 'Anti-epileptic loading', 'EEG monitoring'],
    learningObjectives: [
      'Status epilepticus immediate recognition and management',
      'Stepwise anti-epileptic drug protocol understanding',
      'Time-critical decision making in neurological emergencies'
    ],
    difficulty: 'hard',
    timeLimit: 30,
    scoringCriteria: [
      { category: 'Havayolu yÃ¶netimi', maxPoints: 25, description: 'ABC yaklaÅŸÄ±mÄ± ve havayolu gÃ¼venliÄŸi' },
      { category: 'Benzodiazepin seÃ§imi', maxPoints: 25, description: 'Uygun ilaÃ§ seÃ§imi ve dozlama' },
      { category: 'Zaman yÃ¶netimi', maxPoints: 25, description: 'HÄ±zlÄ± ve etkili karar verme' },
      { category: 'Protokol adherence', maxPoints: 25, description: 'KÄ±lavuz uyumluluÄŸu' }
    ]
  }]
};

// ğŸš¨ VAKA 4: FEBRÄ°L NÃ–TROPENÄ° - ONKOLOJÄ°K ACÄ°L DURUM  
export const febrileNeutropeniaCase: MEPModule = {
  id: 'case-febrile-neutropenia-complete', 
  title: 'ğŸ”¥ VAKA 4: FEBRÄ°L NÃ–TROPENÄ° - ONKOLOJÄ°K ACÄ°L DURUM',
  description: 'Febril nÃ¶tropeni - onkolojik acil durum, empirik antibiyoterapi yaklaÅŸÄ±mÄ±. MASCC skorlamasÄ± ve risk stratifikasyonu ile Turkish Oncology Society guidelines.',
  category: 'oncology',
  language: 'bilingual', 
  resources: [
    'NCCN Fever and Neutropenia Guidelines 2023',
    'MASCC Risk Assessment',
    'Turkish Oncology Society Protocols',
    'Empirical Antibiotic Selection'
  ],
  assessments: ['Risk Stratification', 'Antibiotic Selection', 'MASCC Score Calculation'],
  estimatedTime: 2.0,
  completed: false,
  difficulty: 'advanced',
  aiPrompts: [
    'Febril nÃ¶tropeni risk stratifikasyonu - MASCC vs CISNE scoring',
    'Empirik antibiyotik seÃ§imi - local resistance patterns vs guidelines',
    'Outpatient vs inpatient management criteria'
  ],
  requiredSkills: [
    'Febrile neutropenia recognition',
    'MASCC risk score calculation', 
    'Empirical antibiotic selection',
    'Risk stratification and disposition',
    'Turkish oncology guidelines compliance'
  ],
  turkishMedicalTerms: {
    'febrile neutropenia': 'febril nÃ¶tropeni',
    'neutropenia': 'nÃ¶tropeni',
    'absolute neutrophil count': 'mutlak nÃ¶trofil sayÄ±sÄ±',
    'empirical therapy': 'empirik tedavi',
    'broad-spectrum antibiotics': 'geniÅŸ spektrum antibiyotik',
    'high-risk': 'yÃ¼ksek risk',
    'low-risk': 'dÃ¼ÅŸÃ¼k risk'
  },
  internationalGuidelines: [
    '2023 NCCN Fever and Neutropenia',
    'ESMO Febrile Neutropenia Guidelines',
    'Turkish Society of Medical Oncology 2022'
  ],
  clinicalCases: [{
    id: 'febrile-neutropenia-main',
    title: 'ğŸ”¥ 45Y Female - Febrile Neutropenia Post-Chemo',
    patient: {
      age: 45,
      gender: 'female', 
      chiefComplaint: 'AteÅŸ, titreme, halsizlik',
      history: '7 gÃ¼n Ã¶nce kemoterapisi aldÄ± (AC protokolÃ¼), bugÃ¼n ateÅŸ baÅŸladÄ±, titreme var',
      examination: 'Genel durum orta, ateÅŸli, hafif takipneik, port kateter mevcut',
      investigations: ['Tam kan sayÄ±mÄ±', 'CRP', 'Prokalsitonin', 'Kan kÃ¼ltÃ¼rÃ¼'],
      comorbidities: ['Meme kanseri T2N1M0', 'Adjuvant kemoterapi alÄ±yor']
    },
    presentation: '45 yaÅŸÄ±nda meme kanseri hastasÄ±, 7 gÃ¼n Ã¶nce AC kemoterapi aldÄ±ktan sonra ateÅŸ ve titreme ile baÅŸvurdu.',
    vitalSigns: {
      heartRate: 115,
      bloodPressure: '105/65', 
      temperature: 38.7,
      respiratoryRate: 22,
      oxygenSaturation: 96,
      glasgow: 15
    },
    labResults: [
      { test: 'WBC', value: '1,200/Î¼L (DÃ¼ÅŸÃ¼k)', normalRange: '4,000-11,000/Î¼L', significance: 'critical' },
      { test: 'ANC', value: '400/Î¼L (DÃ¼ÅŸÃ¼k)', normalRange: '>1,500/Î¼L', significance: 'critical' },
      { test: 'Plt', value: '85,000/Î¼L (DÃ¼ÅŸÃ¼k)', normalRange: '150,000-450,000/Î¼L', significance: 'abnormal' },
      { test: 'CRP', value: '45 mg/L (YÃ¼ksek)', normalRange: '<3 mg/L', significance: 'abnormal' },
      { test: 'Prokalsitonin', value: '1.2 ng/mL (YÃ¼ksek)', normalRange: '<0.25 ng/mL', significance: 'abnormal' }
    ],
    decisionTree: [
      {
        id: 'fn-decision-1',
        timePoint: 'Ä°lk deÄŸerlendirme - Risk Stratifikasyonu',
        scenario: 'Kemoterapiden 7 gÃ¼n sonra febril nÃ¶tropeni tanÄ±sÄ± konuldu. Risk deÄŸerlendirmesi yapÄ±lacak.',
        question: 'â“ KARAR NOKTASI 1: RÄ°SK STRATÄ°FÄ°KASYONU\nZaman limiti: 5 dakika\n\nHasta: 45Y, AC kemoterapi +7 gÃ¼n, AteÅŸ: 38.7Â°C, ANC: 400/Î¼L\nECOG PS: 1, Komorbidite: Yok, Hipotansiyon: Yok\n\nMASCC skorunuz ve ilk yaklaÅŸÄ±mÄ±nÄ±z?',
        options: [
          {
            id: 'A',
            text: 'MASCC >21 â†’ outpatient oral antibiyotik',
            isCorrect: false,
            points: 10,
            riskImpact: 1,
            explanation: 'MASCC hesaplama hatalÄ±, bu hasta yÃ¼ksek risk',
            references: ['MASCC Guidelines']
          },
          {
            id: 'B', 
            text: 'MASCC <21 â†’ high-risk, hospitalization + IV antibiyotik',
            isCorrect: true,
            points: 20,
            riskImpact: -2,
            explanation: 'DoÄŸru! Solid tÃ¼mÃ¶r + ANC <500 + serious medical condition = high-risk',
            references: ['NCCN 2023', 'MASCC Score']
          },
          {
            id: 'C',
            text: 'Risk belirsiz, kÃ¼ltÃ¼r sonucu bekle',
            isCorrect: false,
            points: 0,
            riskImpact: 3,
            explanation: 'Febril nÃ¶tropeni medical emergency, kÃ¼ltÃ¼r beklenilmez',
            references: ['Emergency Medicine Guidelines']
          },
          {
            id: 'D',
            text: 'Moderate risk â†’ day hospital monitoring',
            isCorrect: false,
            points: 5,
            riskImpact: 2,
            explanation: 'Bu hasta aÃ§Ä±k high-risk kategorisinde'
          }
        ],
        correctAnswer: 'B',
        explanation: 'âœ… DOÄRU CEVAP: B) MASCC <21 â†’ high-risk, hospitalization + IV antibiyotik\n\nğŸ“ MASCC Hesaplama:\n- Burden of illness: No symptoms (5 puan)\n- No hypotension (5 puan)\n- No COPD (4 puan)\n- Solid tumor/no previous fungal (4 puan)\n- No dehydration (3 puan)\n- Outpatient status (3 puan)\n- Age <60 (0 puan)\nToplam: ~24 puan deÄŸil - ANC <500 severe olduÄŸu iÃ§in high-risk',
        consequences: {
          'A': 'YanlÄ±ÅŸ risk deÄŸerlendirmesi â†’ yetersiz tedavi',
          'B': 'DoÄŸru risk stratifikasyonu â†’ optimal tedavi',
          'C': 'Kritik zaman kaybÄ± â†’ morbidite artÄ±ÅŸÄ±',
          'D': 'Risk altÄ±nda tedavi'
        },
        timeLimit: 300,
        hints: ['MASCC score components gÃ¶zden geÃ§ir', 'ANC <500 major risk factor', 'Medical emergency unutma']
      }
    ],
    diagnosticApproach: ['Fever workup', 'MASCC risk scoring', 'Culture collection', 'Chest imaging'],
    treatment: ['IV empirical antibiotics', 'Supportive care', 'Monitor for complications', 'G-CSF if indicated'],
    learningObjectives: [
      'Febrile neutropenia recognition and risk assessment',
      'MASCC risk score calculation and application',
      'Empirical antibiotic selection principles'
    ],
    difficulty: 'hard',
    timeLimit: 25, 
    scoringCriteria: [
      { category: 'Risk assessment accuracy', maxPoints: 30, description: 'DoÄŸru risk deÄŸerlendirmesi ve MASCC skoru' },
      { category: 'MASCC score calculation', maxPoints: 25, description: 'MASCC risk skoru hesaplama doÄŸruluÄŸu' },
      { category: 'Treatment approach', maxPoints: 25, description: 'Uygun antibiyotik seÃ§imi ve disposition' },
      { category: 'Time management', maxPoints: 20, description: 'HÄ±zlÄ± deÄŸerlendirme ve mÃ¼dahale' }
    ]
  }]
};

// Export complete clinical cases
export const revolutionaryMEPModules: MEPModule[] = [septicShockCase, stemiCase, statusEpilepticusCase, febrileNeutropeniaCase];

// Turkish Medical Education Integration
export const getTurkishMedicalStandards = () => ({
  accreditation: 'TEPDAD (TÄ±p EÄŸitimi ProgramlarÄ±nÄ± DeÄŸerlendirme ve Akreditasyon DerneÄŸi)',
  competencies: [
    'Hasta BakÄ±mÄ±',
    'TÄ±bbi Bilgi', 
    'Uygulamaya DayalÄ± Ã–ÄŸrenme',
    'KiÅŸilerarasÄ± Ä°letiÅŸim',
    'Profesyonellik',
    'Sistem TabanlÄ± Uygulama'
  ],
  examStandards: 'TUS (TÄ±pta UzmanlÄ±k SÄ±navÄ±) StandartlarÄ±',
  guidelines: [
    'Turkish Medical Association (TTB)',
    'Turkish Society of Internal Medicine',
    'Turkish Society of Emergency Medicine',
    'Turkish Society of Cardiology',
    'Turkish Society of Intensive Care'
  ]
});

// AI-Powered Recommendations
export const getAIRecommendations = (userLevel: string, completedCases: string[]): string[] => {
  const recommendations: string[] = [];
  
  if (userLevel === 'student') {
    recommendations.push('Temel clinical reasoning pathways ile baÅŸlayÄ±n');
    recommendations.push('Pattern recognition training\'e odaklanÄ±n');
  } else if (userLevel === 'resident') {
    if (!completedCases.includes('case-septic-shock-complete')) {
      recommendations.push('Septic shock case - acil tÄ±p rotasyonu iÃ§in kritik');
    }
    if (!completedCases.includes('case-stemi-complete')) {
      recommendations.push('STEMI case - kardiyoloji rotasyonu iÃ§in essential');
    }
  }
  
  return recommendations;
};

// Export all modules organized by student level
export const medicalStudentMEPs: MEPModule[] = [septicShockCase, stemiCase];
export const medicalResidentMEPs: MEPModule[] = [statusEpilepticusCase, febrileNeutropeniaCase];
export const allMEPModules = revolutionaryMEPModules;